Literature DB >> 12357282

Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor.

David S Goldstein1, Courtney Holmes, Raghuveer Dendi, Sheng-Ting Li, Sandra Brentzel, Steven Vernino.   

Abstract

We report the case of a patient with chronic autonomic failure who had evidence of decreased postganglionic traffic to intact sympathetic nerve terminals. The patient complained mainly of decreased salivation, constipation, dry skin, and orthostatic intolerance. There was no evidence of central neurodegeneration. Autonomic function testing showed orthostatic hypotension without tachycardia and abnormal blood pressure and pulse rate responses to the Valsalva maneuver, indicating combined sympathetic and parasympathetic neurocirculatory failure. In contrast to patients with pure autonomic failure, the patient had normal left ventricular myocardial concentrations of 6-[(18)F]fluorodopamine-derived radioactivity, establishing intact postganglionic sympathetic innervation; and in contrast to patients with multiple system atrophy or baroreflex failure, the patient had a low plasma norepinephrine concentration and brisk norepinephrine response to orthostasis. These findings indicated an impediment to ganglionic neurotransmission. Serologic testing demonstrated a circulating antibody to the ganglionic nicotinic acetylcholine receptor. The findings in this case support the concept that circulating antibodies to this receptor can interfere with ganglionic neurotransmission and produce autoimmune autonomic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12357282     DOI: 10.1007/s10286-002-0020-3

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  22 in total

1.  Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Authors:  David S Goldstein; Courtney Holmes; Patti Sullivan; Deborah C Mash; Ellen Sidransky; Alessandro Stefani; Irwin J Kopin; Yehonatan Sharabi
Journal:  Parkinsonism Relat Disord       Date:  2015-07-17       Impact factor: 4.891

2.  Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure.

Authors:  Richard Imrich; David S Goldstein; David M Jacobowitz
Journal:  Clin Auton Res       Date:  2006-09-14       Impact factor: 4.435

3.  Autoimmunity-associated autonomic failure with sympathetic denervation.

Authors:  David S Goldstein; Courtney Holmes; Patti Sullivan; Vincenzo Donadio; Risa Isonaka; Elizabeth Zhong; Bobby Pourier; Steven Vernino; Irwin J Kopin; Yehonatan Sharabi
Journal:  Clin Auton Res       Date:  2016-11-12       Impact factor: 4.435

4.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

5.  Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.

Authors:  Ryan Hollenbeck; Bonnie K Black; Amanda C Peltier; Italo Biaggioni; David Robertson; Elliott F Winton; Satish R Raj
Journal:  Arch Neurol       Date:  2010-11-08

Review 6.  Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy.

Authors:  Steven Vernino; Steve Hopkins; Zhengbei Wang
Journal:  Auton Neurosci       Date:  2008-10-31       Impact factor: 3.145

7.  Sudomotor dysfunction in autoimmune autonomic ganglionopathy.

Authors:  K Kimpinski; V Iodice; P Sandroni; R D Fealey; S Vernino; P A Low
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

8.  Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer.

Authors:  Amanda C Peltier; Bonnie K Black; Satish R Raj; Peter Donofrio; David Robertson; Italo Biaggioni
Journal:  Muscle Nerve       Date:  2010-03       Impact factor: 3.217

9.  Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab.

Authors:  Richard Imrich; Steven Vernino; Basil A Eldadah; Courtney Holmes; David S Goldstein
Journal:  Clin Auton Res       Date:  2009-04-28       Impact factor: 4.435

Review 10.  Invited Article: Autonomic ganglia: target and novel therapeutic tool.

Authors:  Steven Vernino; Paola Sandroni; Wolfgang Singer; Phillip A Low
Journal:  Neurology       Date:  2008-05-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.